BR112022024382A2 - Formas sólidas de pralsetinibe - Google Patents

Formas sólidas de pralsetinibe

Info

Publication number
BR112022024382A2
BR112022024382A2 BR112022024382A BR112022024382A BR112022024382A2 BR 112022024382 A2 BR112022024382 A2 BR 112022024382A2 BR 112022024382 A BR112022024382 A BR 112022024382A BR 112022024382 A BR112022024382 A BR 112022024382A BR 112022024382 A2 BR112022024382 A2 BR 112022024382A2
Authority
BR
Brazil
Prior art keywords
pralsetinib
forms
solid forms
solid
pyrazol
Prior art date
Application number
BR112022024382A
Other languages
English (en)
Inventor
Waetzig Joshua
D Wilkie Gordon
Maceachern Lauren
Jean Miller Kimberly
Original Assignee
Blueprint Medicines Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blueprint Medicines Corp filed Critical Blueprint Medicines Corp
Publication of BR112022024382A2 publication Critical patent/BR112022024382A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

FORMAS SÓLIDAS DE PRALSETINIBE. O composto cis)-N-((S)-1-(6-(4-fluoro-1H-pirazol-1-il)piridin-3-il)etil)-1-metoxi-4-(4-metil-6-(5-metil-1H-pirazol-3-ilamino)pirimidin-2-il)ciclo-hexanocarboxamida pode ser preparado como uma base livre em várias formas sólidas cristalinas e em várias formas de sal, cada uma tendo uma ou mais formas sólidas.
BR112022024382A 2020-05-29 2021-05-28 Formas sólidas de pralsetinibe BR112022024382A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063032121P 2020-05-29 2020-05-29
US202063047353P 2020-07-02 2020-07-02
PCT/US2021/034823 WO2021243192A1 (en) 2020-05-29 2021-05-28 Solid forms of pralsetinib

Publications (1)

Publication Number Publication Date
BR112022024382A2 true BR112022024382A2 (pt) 2023-05-02

Family

ID=76601779

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022024382A BR112022024382A2 (pt) 2020-05-29 2021-05-28 Formas sólidas de pralsetinibe

Country Status (12)

Country Link
US (1) US20230295121A1 (pt)
EP (1) EP4157829A1 (pt)
JP (1) JP2023527412A (pt)
KR (1) KR20230017234A (pt)
CN (1) CN116075503A (pt)
AU (1) AU2021281365A1 (pt)
BR (1) BR112022024382A2 (pt)
CA (1) CA3183728A1 (pt)
IL (1) IL298523A (pt)
MX (1) MX2022014858A (pt)
TW (1) TW202210468A (pt)
WO (1) WO2021243192A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20240124T1 (hr) 2018-04-03 2024-04-12 Blueprint Medicines Corporation Inhibitori za ret za uporabu u liječenju raka koji ima ret alteraciju
US20230391746A1 (en) * 2020-10-19 2023-12-07 Teva Pharmaceuticals International Gmbh Solid state forms of pralsetinib and process for preparation thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ742351A (en) 2015-11-02 2023-03-31 Blueprint Medicines Corp Inhibitors of ret

Also Published As

Publication number Publication date
WO2021243192A1 (en) 2021-12-02
IL298523A (en) 2023-01-01
TW202210468A (zh) 2022-03-16
JP2023527412A (ja) 2023-06-28
EP4157829A1 (en) 2023-04-05
MX2022014858A (es) 2023-02-23
CN116075503A (zh) 2023-05-05
KR20230017234A (ko) 2023-02-03
US20230295121A1 (en) 2023-09-21
AU2021281365A1 (en) 2022-12-15
CA3183728A1 (en) 2021-12-02

Similar Documents

Publication Publication Date Title
BR112022024382A2 (pt) Formas sólidas de pralsetinibe
BR112022003375A2 (pt) Compostos de pirazina-amida pesticidamente ativos
MX2020014165A (es) Compuestos de azol-amida pesticidamente activos.
NO20074431L (no) Pyrrolopyrimidiner nyttige som proteinkinaseinhibitorer
CO2021013183A2 (es) Compuestos de diazina-amida activos como pesticidas
CO2021013350A2 (es) Compuestos de diazina-amida activos como pesticidas
SG167664A1 (en) 2,4-pyrimidinediamine compounds and their uses
EA200800201A1 (ru) Кристаллические формы 4-метил-n-[3-(4-метилимидазол-1-ил)-5-трифторметилфенил]-3-(4-пиридин-3-илпиримидин-2-иламино)бензамида
HRP20041177B1 (hr) Mikrobicidni pirimidini ili triazini za prevenciju prijenosa hiv seksualnim putem
ATE518010T1 (de) Aktive oberflächengekoppelte polymerasen
CO2021012549A2 (es) Compuestos de diazina-amida activos como pesticidas
EA200801406A1 (ru) Антагонисты активина-actriia и их применение для стимулирования роста кости
ATE517896T1 (de) P38-kinase-inhibitoren
NO20070699L (no) Spesielle aminoalkylglukosaminidfosfatforbindelser og deres anvendelse
PE20200329A1 (es) Procedimiento para establecer permisos de usuario en unidad de intercambio de informacion en el sistema
NO20072890L (no) Behandling av mastitt
UY34191A (es) ?N-(6-((2R,3S)-3,4-Dihidroxibutan-2-iloxi)-2-(4-fluorobenciltio)pirimidin-4-il)-3-metilazetidina-1-sulfonamida y sales farmacéuticamente aceptables de lamisma?.
BR112022004917A2 (pt) Compostos de amina cíclica pesticidamente ativos
CY1112121T1 (el) ΠΑΡΑΓΩΓΑ ΤΩΝ 1,2,3,4-ΤΕΤΡΑΫΔΡΟΠΥΡΡΟΛΟ-[1,2-α]-ΠΥΡΑΖΙΝ-6-ΚΑΡΒΟΞΑΜΙΔΙΩΝ ΚΑΙ ΤΩΝ 2,3,4,5-ΤΕΤΡΑΫΔΡΟΠΥΡΡΟΛΟ-(1,2-α)-ΔΙΑΖΕΠΙΝ-7-ΚΑΡΒΟΞΑΜΙΔΙΩΝ, Η ΠΑΡΑΣΚΕΥΗ ΤΟΥΣ ΚΑΙ Η ΕΦΑΡΜΟΓΗ ΤΟΥΣ ΣΕ ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ
EA200601176A1 (ru) 3-цианохинолиновые производные с антипролиферативной активностью
BRPI0518700B8 (pt) combinação contendo vegf-trap, 5-fluorouracila e ácido folínico
BRPI0511125A (pt) usos de ácido 5,6,7-triidroxieptanóico seus e análogos
SE0301654D0 (sv) Novel compounds
BR0307286A (pt) Tratamento de artrite reumatóide usando imatinib
PL420532A1 (pl) Zastosowanie 3-(4-bromofenetylo)-6-(tert-butylo)-3,4-dihydro-2H-benzo[1,3]oksazyny